Proliferative vitreoretinopathy and its relationship with inflammatory serum biomarkers

dc.contributor.authorVictor Alejandro Martinez Pacheco
dc.contributor.authorSergio Rojas Juárez
dc.contributor.authorBraulio Hernan Velasco Sepulveda
dc.contributor.authorA. Ramírez Estudillo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:22:33Z
dc.date.available2026-03-22T19:22:33Z
dc.date.issued2024
dc.description.abstractPatients with primary PVR demonstrate greater neutrophil, monocyte, and LMR levels than the control group. Cut-off values obtained from ratios could be useful in a clinical setting when no posterior view of the fundus is possible due to media opacity.
dc.identifier.doi10.18240/ijo.2024.09.13
dc.identifier.urihttps://doi.org/10.18240/ijo.2024.09.13
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/75684
dc.language.isoen
dc.publisherPress of International Journal of Ophthalmology (IJO PRESS)
dc.relation.ispartofInternational Journal of Ophthalmology
dc.sourceUniversidad Nuestra Señora de La Paz
dc.subjectMedicine
dc.subjectProliferative vitreoretinopathy
dc.subjectInflammation
dc.subjectOphthalmology
dc.titleProliferative vitreoretinopathy and its relationship with inflammatory serum biomarkers
dc.typearticle

Files